Allosteric modulation of estrogen receptor conformation by different estrogen response elements.

Estrogen-regulated gene expression is dependent on interaction of the estrogen receptor (ER) with the estrogen response element (ERE). We assessed the ability of the ER to activate transcription of reporter plasmids containing either the consensus vitellogenin A2 ERE or the imperfect pS2, vitellogenin B1, or oxytocin (OT) ERE. The A2 ERE was the most potent activator of transcription. The OT ERE was significantly more effective in activating transcription than either the pS2 or B1 ERE. In deoxyribonuclease I (DNase I) footprinting experiments, MCF-7 proteins protected A2 and OT EREs more effectively than the pS2 and B1 EREs. Limited protease digestion of the A2, pS2, B1, or OT ERE-bound receptor with V8 protease or proteinase K produced distinct cleavage products demonstrating that individual ERE sequences induce specific changes in ER conformation. Receptor interaction domains of glucocorticoid receptor interacting protein 1 and steroid receptor coactivator 1 bound effectively to the A2, pS2, B1, and OT ERE-bound receptor and significantly stabilized the receptor-DNA interaction. Similar levels of the full-length p160 protein amplified in breast cancer 1 were recruited from HeLa nuclear extracts by the A2, pS2, B1, and OT ERE-bound receptors. In contrast, significantly less transcriptional intermediary factor 2 was recruited by the B1 ERE-bound receptor than by the A2 ERE-bound receptor. These studies suggest that allosteric modulation of ER conformation by individual ERE sequences influences the recruitment of specific coactivator proteins and leads to differential expression of genes containing divergent ERE sequences.

[1]  P. Chambon,et al.  Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7. , 1987, Endocrinology.

[2]  Raina M. Miller Biosurfactant-facilitated remediation of metal-contaminated soils , 1995 .

[3]  S. Hahn Clamping the TBP stirrup , 1995, Nature.

[4]  Christopher K. Glass,et al.  The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function , 1997, Nature.

[5]  H Grøn,et al.  Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Direnzo,et al.  p300 is a component of an estrogen receptor coactivator complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Nardulli,et al.  The role of estrogen response elements in expression of the Xenopus laevis vitellogenin B1 gene. , 1992, Molecular endocrinology.

[8]  Y. Liu,et al.  Thyroid Hormone Response Elements Differentially Modulate the Interactions of Thyroid Hormone Receptors with Two Receptor Binding Domains in the Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.

[9]  D. Galas,et al.  Escherichia coli integration host factor bends the DNA at the ends of IS1 and in an insertion hotspot with multiple IHF binding sites. , 1987, The EMBO journal.

[10]  M. Parker,et al.  Molecular Determinants of the Estrogen Receptor-Coactivator Interface , 1999, Molecular and Cellular Biology.

[11]  J. Lee,et al.  Interdomain Signaling in a Two-domain Fragment of the Human Glucocorticoid Receptor* , 1999, The Journal of Biological Chemistry.

[12]  B. Katzenellenbogen,et al.  Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. , 1991, Nucleic acids research.

[13]  Gerhart U. Ryffel,et al.  An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells , 1986, Cell.

[14]  J. Stevenson,et al.  THE METABOLIC AND CARDIOVASCULAR CONSEQUENCES OF HRT , 1995, The British journal of clinical practice.

[15]  C. Glass,et al.  Co-activators and co-repressors in the integration of transcriptional responses. , 1998, Current opinion in cell biology.

[16]  G. Greene,et al.  Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. , 1996, Molecular endocrinology.

[17]  P. Lieberman,et al.  Two distinct domains in the yeast transcription factor IID and evidence for a TATA box-induced conformational change , 1991, Molecular and cellular biology.

[18]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[19]  J. Bahr,et al.  Sperm, a source of estrogen. , 1995, Environmental health perspectives.

[20]  G. Stein,et al.  Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. , 1996, Molecular endocrinology.

[21]  D. Robyr,et al.  Nuclear hormone receptor coregulators in action: diversity for shared tasks. , 2000, Molecular endocrinology.

[22]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[23]  B. O’Malley,et al.  Specific binding of estrogen receptor to the estrogen response element , 1989, Molecular and cellular biology.

[24]  John W. R. Schwabe,et al.  The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements , 1993, Cell.

[25]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[26]  M. Brown-Luedi,et al.  Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes. , 1984, Nucleic acids research.

[27]  K. Yamamoto,et al.  Intracellular receptors use a common mechanism to interpret signaling information at response elements. , 1996, Genes & development.

[28]  G. Nolan,et al.  Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. , 1992, Genes & development.

[29]  K. Horwitz,et al.  The N-terminal Region of the Human Progesterone A-receptor , 2000, The Journal of Biological Chemistry.

[30]  J. Gustafsson,et al.  The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens , 1997, FEBS letters.

[31]  S. Khorasanizadeh,et al.  Structure of the RXR–RAR DNA‐binding complex on the retinoic acid response element DR1 , 2000, The EMBO journal.

[32]  J. Battey,et al.  The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. , 1985, The Journal of biological chemistry.

[33]  J. Katzenellenbogen,et al.  Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. , 1995, Biochemistry.

[34]  M. Stallcup,et al.  Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. , 1998, Molecular Endocrinology.

[35]  M. Yaniv,et al.  Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma , 1984, Cell.

[36]  B. O’Malley,et al.  Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). , 1992, The Journal of biological chemistry.

[37]  M. Garabedian,et al.  GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors , 1997, Molecular and cellular biology.

[38]  B. Katzenellenbogen,et al.  Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. , 1987, Cancer research.

[39]  J. Schwabe,et al.  The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation. , 1995, Structure.

[40]  P. Chambon,et al.  TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.

[41]  B. O’Malley,et al.  Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. , 1993, Molecular endocrinology.

[42]  J. Gorski,et al.  Conformational transitions of the estrogen receptor monomer. Effects of estrogens, antiestrogen, and temperature. , 1986, The Journal of biological chemistry.

[43]  R T Turner,et al.  Skeletal effects of estrogen. , 1994, Endocrine reviews.

[44]  S. Buratowski,et al.  Mobility Shift DNA‐Binding Assay Using Gel Electrophoresis , 2001, Current protocols in pharmacology.

[45]  P. Kushner,et al.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.

[46]  G. Ryffel,et al.  A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. , 1988, Nucleic acids research.

[47]  Myles Brown,et al.  Polarity-specific activities of retinoic acid receptors determined by a co-repressor , 1995, Nature.

[48]  Donald F. Senear,et al.  [9] Quantitative DNase footprint titration: A method for studying protein-DNA interactions , 1986 .

[49]  Jeffrey A. Lefstin,et al.  Allosteric effects of DNA on transcriptional regulators , 1998, Nature.

[50]  G. Greene,et al.  Estrogen Response Elements Function as Allosteric Modulators of Estrogen Receptor Conformation , 1998, Molecular and Cellular Biology.

[51]  X. Jacq,et al.  Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor , 1994, Cell.

[52]  B. O’Malley,et al.  CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Greene,et al.  Human estrogen receptor bound to an estrogen response element bends DNA. , 1993, Molecular endocrinology.

[54]  J. Gustafsson,et al.  Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. , 1997, Molecular endocrinology.

[55]  J. T. Kadonaga,et al.  p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. , 1998, Genes & development.

[56]  P. Chambon,et al.  The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer , 1988, Cell.

[57]  M. Rosenfeld,et al.  Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. , 2000, Science.

[58]  B. Katzenellenbogen,et al.  Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen. , 1990, Endocrinology.

[59]  T. Richmond,et al.  DNA binding-induced conformational change of the yeast transcriptional activator PRTF , 1990, Cell.